In the week of April 6, 2026, 30 holders filed a new Schedule 13D and 180 a new Schedule 13G reporting 5% or more of a company, and 3 13D filings stated an intent to influence the company. The largest stake reported that week is BlackRock Portfolio Management LLC's 100% of iShares MSCI Japan Value ETF (Schedule 13G, April 7, 2026).
New 13D30
New 13G180
Stated intents3
The week of 2026-04-06, 30 holders filed a new Schedule 13D and 180 a new Schedule 13G reporting 5% or more of a company, and 3 13D filings stated in Item 4 an intent to influence the company. Open a company for every holder and the purpose each 13D states, quoted.
New Schedule 13D
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-04-09 | Banzai International, Inc. | Joseph Davy | 100% | SCHEDULE 13D |
| 2026-04-10 | K-Tech Solutions Co Ltd | Kwok Yiu Keung | 72.29% | SCHEDULE 13D |
| 2026-04-08 | Hawkeye Systems, Inc. | Hawkeye HoldCo LLC | 69.1% | SCHEDULE 13D |
| 2026-04-07 | Moolec Science SA | Agriculture Investment Group Corp. | 65.1% | SCHEDULE 13D |
| 2026-04-06 | Cementos Pacasmayo Saa | Holcim Ltd | 50.01% | SCHEDULE 13D |
| 2026-04-08 | Xanadu Quantum Technologies Limited | Georgian Partners Growth Fund (International) IV, LP | 40.8% | SCHEDULE 13D |
| 2026-04-10 | VASO Corp | Joshua Markowitz | 31.9% | SCHEDULE 13D |
| 2026-04-06 | Greenland Energy Company | Price Robert B. | 28.3% | SCHEDULE 13D |
| 2026-04-08 | Longevity Health Holdings, Inc. | Ajjarapu J. Ram | 27.9% | SCHEDULE 13D |
| 2026-04-07 | OnKure Therapeutics, Inc. | AI Biotechnology LLC | 19.99% | SCHEDULE 13D |
| 2026-04-10 | Tessera Defense and Homeland Security Inc. | T3 Defense Inc. | 19.87% | SCHEDULE 13D |
| 2026-04-08 | E-Home Household Service Holdings Ltd | Wenshan Xie | 17.26% | SCHEDULE 13D |
| 2026-04-07 | CoinShares PLC | Mognetti Jean-Marie | 16.4% | SCHEDULE 13D |
| 2026-04-07 | CoinShares PLC | Daniel Masters | 16.3% | SCHEDULE 13D |
| 2026-04-06 | Apellis Pharmaceuticals, Inc. | Biogen Inc. | 14.2% | SCHEDULE 13D |
| 2026-04-08 | Xerox Holdings Corp | Douglas R. Deason | 11.29% | SCHEDULE 13D |
| 2026-04-08 | Xerox Holdings Corp | DD Revocable Trust | 11.29% | SCHEDULE 13D |
| 2026-04-07 | Strata Critical Medical, Inc. | Krstic Velibor | 8.3% | SCHEDULE 13D |
| 2026-04-08 | SharonAI Holdings Inc. | Nicholas Hughes-Jones | 8.1% | SCHEDULE 13D |
| 2026-04-08 | Blue Bird Corp | Groupe Autobus Girardin Ltee | 7.88% | SCHEDULE 13D |
| 2026-04-09 | Service Properties Trust | The RMR Group LLC | 6.75% | SCHEDULE 13D |
| 2026-04-06 | Frontview Reit Inc | Charles Fitzgerald | 6.7% | SCHEDULE 13D |
| 2026-04-10 | Galera Therapeutics, Inc. | Chang Nancy T | 5.9% | SCHEDULE 13D |
| 2026-04-10 | Loop Industries, Inc. | Global Value Investment Corporation | 5.85% | SCHEDULE 13D |
| 2026-04-08 | Chegg, Inc. | Galloway Capital Partners, LLC | 5.44% | SCHEDULE 13D |
| 2026-04-08 | Apollomics Inc. | Yi-Kuei Chen | 5.3% | SCHEDULE 13D |
| 2026-04-06 | Colliers International Group Inc | Spruce House Investment Management LLC | 5.13% | SCHEDULE 13D |
| 2026-04-09 | InMode Ltd. | Michael Kreindel | 5.11% | SCHEDULE 13D |
| 2026-04-09 | PAVmed Inc. | Aklog Lishan | 5.1% | SCHEDULE 13D |
| 2026-04-06 | Associated Banc-Corp | Wende L. Kotouc | 5.09% | SCHEDULE 13D |
New Schedule 13G
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-04-07 | iShares MSCI Japan Value ETF | BlackRock Portfolio Management LLC | 100% | SCHEDULE 13G |
| 2026-04-07 | iShares MSCI Japan Value ETF | BlackRock Portfolio Management LLC | 100% | SCHEDULE 13G |
| 2026-04-07 | iShares MSCI Japan Value ETF | BlackRock Portfolio Management LLC | 100% | SCHEDULE 13G |
| 2026-04-07 | iShares Managed Futures Active ETF | BlackRock Portfolio Management LLC | 90.9% | SCHEDULE 13G |
| 2026-04-07 | iShares MSCI Japan Value ETF | BlackRock Portfolio Management LLC | 88.9% | SCHEDULE 13G |
| 2026-04-07 | iShares MSCI Japan Value ETF | BlackRock Portfolio Management LLC | 88.9% | SCHEDULE 13G |
| 2026-04-07 | iShares MSCI Japan Value ETF | BlackRock Portfolio Management LLC | 88.9% | SCHEDULE 13G |
| 2026-04-07 | iShares MSCI Australia ETF | BlackRock Portfolio Management LLC | 73.4% | SCHEDULE 13G |
| 2026-04-07 | First Trust Exchange-Traded AlphaDEX(R) Fund | First Trust Portfolios L.P. | 58.02% | SCHEDULE 13G |
| 2026-04-06 | Turn Therapeutics Inc. | Bradley Burnam | 52.76% | SCHEDULE 13G |
| 2026-04-07 | iShares MSCI Japan Value ETF | BlackRock Portfolio Management LLC | 50% | SCHEDULE 13G |
| 2026-04-07 | iShares MSCI Japan Value ETF | BlackRock Portfolio Management LLC | 50% | SCHEDULE 13G |
| 2026-04-08 | Xanadu Quantum Technologies Limited | OMERS ADMINISTRATION Corp | 48.5% | SCHEDULE 13G |
| 2026-04-07 | First Trust Exchange-Traded Fund VIII | First Trust Portfolios L.P. | 37.5% | SCHEDULE 13G |
| 2026-04-07 | iShares MSCI Japan Value ETF | BlackRock Portfolio Management LLC | 33.3% | SCHEDULE 13G |
| 2026-04-07 | Sterling Capital Funds | Truist Financial Corp | 32.2% | SCHEDULE 13G |
| 2026-04-07 | First Trust Exchange-Traded Fund VIII | First Trust Portfolios L.P. | 30.76% | SCHEDULE 13G |
| 2026-04-07 | iShares Staked Ethereum Trust ETF | BlackRock Portfolio Management LLC | 26.5% | SCHEDULE 13G |
| 2026-04-09 | Metals Royalty Co Inc. | TMC the metals company Inc. | 25.15% | SCHEDULE 13G |
| 2026-04-07 | iShares MSCI Japan Value ETF | BlackRock Portfolio Management LLC | 21% | SCHEDULE 13G |
| 2026-04-07 | First Trust Exchange-Traded Fund VIII | First Trust Portfolios L.P. | 17.07% | SCHEDULE 13G |
| 2026-04-07 | iShares MSCI Japan Value ETF | BlackRock Portfolio Management LLC | 16.3% | SCHEDULE 13G |
| 2026-04-09 | Xanadu Quantum Technologies Limited | MMCAP International Inc. SPC | 15.9% | SCHEDULE 13G |
| 2026-04-07 | iShares MSCI Australia ETF | BlackRock Portfolio Management LLC | 15.8% | SCHEDULE 13G |
| 2026-04-07 | Tyra Biosciences Inc | Fmr LLC | 14.4% | SCHEDULE 13G |
| 2026-04-07 | Promis Neurosciences Inc. | Janus Henderson Group Plc | 14.4% | SCHEDULE 13G |
| 2026-04-07 | Femto Technologies Inc. | Batya Ben Yakov | 13.6% | SCHEDULE 13G |
| 2026-04-07 | Sphere Entertainment Co. | BlackRock, Inc. | 13.5% | SCHEDULE 13G |
| 2026-04-07 | First Trust Exchange-Traded Fund VIII | First Trust Portfolios L.P. | 13.21% | SCHEDULE 13G |
| 2026-04-07 | iShares MSCI Japan Value ETF | FIL Limited | 12.9% | SCHEDULE 13G |
| 2026-04-07 | Sunbelt Rentals Holdings Inc | Dodge & Cox | 12.8% | SCHEDULE 13G |
| 2026-04-06 | Better Home & Finance Holding Company | Spencer Vance | 12.4% | SCHEDULE 13G |
| 2026-04-07 | PRESIDIO PRODUCTION Co | EQV Resources Intermediate LLC | 12.4% | SCHEDULE 13G |
| 2026-04-07 | iShares MSCI Australia ETF | BlackRock Portfolio Management LLC | 12.2% | SCHEDULE 13G |
| 2026-04-06 | Nuveen Real Asset Income and Growth Fund | Sit Investment Associates, Inc. | 12.1% | SCHEDULE 13G |
| 2026-04-07 | Strive Inc | Fmr LLC | 12.1% | SCHEDULE 13G |
| 2026-04-09 | Netcapital Inc. | Rivetz Corp. | 12.1% | SCHEDULE 13G |
| 2026-04-07 | Lyft Inc | BlackRock, Inc. | 11.7% | SCHEDULE 13G |
| 2026-04-07 | Haymaker Acquisition Corp. 4 | American Century Investment Management, Inc. | 11.6% | SCHEDULE 13G |
| 2026-04-07 | KEMPER Corp | BlackRock, Inc. | 11.4% | SCHEDULE 13G |
| 2026-04-06 | Versamet Royalties Corp | Equinox Gold Corp. | 11% | SCHEDULE 13G |
| 2026-04-07 | Life360, Inc. | BlackRock, Inc. | 11% | SCHEDULE 13G |
| 2026-04-07 | Hni Corp | Fmr LLC | 10.9% | SCHEDULE 13G |
| 2026-04-07 | Metals Acquisition Corp. II | Mudita Advisors LLP | 10.9% | SCHEDULE 13G |
| 2026-04-08 | Esab Corp | T. Rowe Price Associates, Inc. | 10.9% | SCHEDULE 13G |
| 2026-04-08 | Jeld-Wen Holding Inc | Bank Of Nova Scotia | 10.81% | SCHEDULE 13G |
| 2026-04-07 | Starz Entertainment Corp. | Bank of Montreal | 10.75% | SCHEDULE 13G |
| 2026-04-07 | Sunopta Inc | FIL Limited | 10.7% | SCHEDULE 13G |
| 2026-04-07 | Amplitude Inc | Wellington Management Group LLP | 10.7% | SCHEDULE 13G |
| 2026-04-07 | Amplitude Inc | Wellington Management Group LLP | 10.7% | SCHEDULE 13G |
| 2026-04-07 | iShares MSCI Japan Value ETF | BlackRock, Inc. | 10.7% | SCHEDULE 13G |
| 2026-04-08 | Marcus Corp | Marcus Gregory S | 10.66% | SCHEDULE 13G |
| 2026-04-07 | News Corp | State Street Corporation | 10.6% | SCHEDULE 13G |
| 2026-04-07 | Paycom Software, Inc. | BlackRock, Inc. | 10.6% | SCHEDULE 13G |
| 2026-04-07 | ZoomInfo Technologies Inc | BlackRock, Inc. | 10.6% | SCHEDULE 13G |
| 2026-04-07 | Phibro Animal Health Corporation | Fmr LLC | 10.5% | SCHEDULE 13G |
| 2026-04-07 | Trade Desk Inc | State Street Corporation | 10.4% | SCHEDULE 13G |
| 2026-04-07 | Bluemount Holdings Ltd | Luk Tung Lam | 10.3% | SCHEDULE 13G |
| 2026-04-06 | Maase Inc. | YCY Management Company Limited | 10.18% | SCHEDULE 13G |
| 2026-04-07 | T Rowe Price Group Inc | BlackRock, Inc. | 10.1% | SCHEDULE 13G |
| 2026-04-07 | Keros Therapeutics, Inc. | BlackRock, Inc. | 10.1% | SCHEDULE 13G |
| 2026-04-07 | Science Applications International Corp | BlackRock, Inc. | 10.1% | SCHEDULE 13G |
| 2026-04-07 | iShares MSCI Japan Value ETF | BlackRock Portfolio Management LLC | 10.1% | SCHEDULE 13G |
| 2026-04-07 | iShares MSCI Australia ETF | BlackRock Portfolio Management LLC | 10.1% | SCHEDULE 13G |
| 2026-04-06 | Centerspace | Vanguard Portfolio Management | 10.02% | SCHEDULE 13G |
| 2026-04-07 | Casey's General Stores Inc | BlackRock, Inc. | 10% | SCHEDULE 13G |
| 2026-04-08 | Atrium Therapeutics, Inc. | T. Rowe Price Associates, Inc. | 10% | SCHEDULE 13G |
| 2026-04-07 | SCYNEXIS, Inc. | Great Point Partners, LLC | 9.99% | SCHEDULE 13G |
| 2026-04-08 | Pasithea Therapeutics Corp. | Opaleye Management Inc. | 9.99% | SCHEDULE 13G |
| 2026-04-06 | VivoSim Labs, Inc. | Esousa Group Holdings LLC | 9.9% | SCHEDULE 13G |
| 2026-04-07 | OnKure Therapeutics, Inc. | RA Capital Management, L.P. | 9.9% | SCHEDULE 13G |
| 2026-04-07 | Aprea Therapeutics, Inc. | Squadron Master Fund LP | 9.9% | SCHEDULE 13G |
| 2026-04-07 | Brand Engagement Network Inc | Joseph Bevash | 9.8% | SCHEDULE 13G |
| 2026-04-08 | SCYNEXIS, Inc. | Squadron Master Fund LP | 9.6% | SCHEDULE 13G |
| 2026-04-08 | Service Properties Trust | FF Hybrid, LP | 9.4% | SCHEDULE 13G |
| 2026-04-09 | Barfresh Food Group Inc. | Justin B. Borus | 9% | SCHEDULE 13G |
| 2026-04-10 | Brookfield Business Partners LP | OMERS Administration Corporation | 8.7% | SCHEDULE 13G |
| 2026-04-07 | Service Properties Trust | Helix Partners Management LP | 8.6% | SCHEDULE 13G |
| 2026-04-08 | PAVmed Inc. | Nagelberg David S | 8.6% | SCHEDULE 13G |
| 2026-04-08 | GigCapital9 Corp. | Yakira Capital Management, Inc. | 8.48% | SCHEDULE 13G |
| 2026-04-09 | Nine Energy Service, Inc. | CastleKnight Master Fund LP | 8.3% | SCHEDULE 13G |
| 2026-04-07 | Fortress Private Lending Fund | The Heising-Simons Foundation | 8.2% | SCHEDULE 13G |
| 2026-04-07 | Nuveen S&P 500 Dynamic Overwrite Fund | Raymond James Financial Services Advisors, Inc. | 8.2% | SCHEDULE 13G |
| 2026-04-08 | Spacsphere Acquisition Corp. | Yakira Capital Management, Inc. | 8.16% | SCHEDULE 13G |
| 2026-04-06 | Nuveen Pennsylvania Quality Municipal Income Fund | Sit Investment Associates, Inc. | 8.1% | SCHEDULE 13G |
| 2026-04-06 | Nuveen Pennsylvania Quality Municipal Income Fund | Sit Investment Associates, Inc. | 8.1% | SCHEDULE 13G |
| 2026-04-07 | PFS Bancorp, Inc. | Raymond James Financial Services Advisors, Inc. | 8.1% | SCHEDULE 13G |
| 2026-04-09 | The ONE Group Hospitality, Inc. | Nicholas Giannuzzi | 8% | SCHEDULE 13G |
| 2026-04-08 | PS International Group Ltd. | Xiaoqing Zhu | 7.98% | SCHEDULE 13G |
| 2026-04-08 | PS International Group Ltd. | Yudian Liu | 7.94% | SCHEDULE 13G |
| 2026-04-09 | Escalon Medical Corp. | LPL Financial LLC | 7.9% | SCHEDULE 13G |
| 2026-04-09 | PS International Group Ltd. | Jing Liu | 7.86% | SCHEDULE 13G |
| 2026-04-09 | Nixxy, Inc. | NexGenAI Holding Group, Inc. | 7.79% | SCHEDULE 13G |
| 2026-04-08 | HMH Holding Inc. | Encompass Capital Advisors LLC | 7.6% | SCHEDULE 13G |
| 2026-04-08 | iWallet Corp | Killuminati Investments LLC | 7.5% | SCHEDULE 13G |
| 2026-04-06 | Azul S.A. | Thomas A. Wagner III | 7.4% | SCHEDULE 13G |
| 2026-04-07 | Oxford Lane Capital Corp. | Leroy Scott Frantz | 7.1% | SCHEDULE 13G |
| 2026-04-07 | Curis, Inc. | Nantahala Capital Partners Limited Partnership | 6.98% | SCHEDULE 13G |
| 2026-04-08 | Eagle Nuclear Energy Corp. | Naranjan Singh Parhar | 6.86% | SCHEDULE 13G |
| 2026-04-09 | Globaltech Corp | CricksLab L.L.C-FZ | 6.7% | SCHEDULE 13G |
| 2026-04-07 | Xanadu Quantum Technologies Limited | GIC Private Ltd | 6.68% | SCHEDULE 13G |
| 2026-04-09 | Kensington Capital Acquisition Corp. VI | Wealthspring Capital LLC | 6.63% | SCHEDULE 13G |
| 2026-04-07 | OnKure Therapeutics, Inc. | StepStone Group LP | 6.6% | SCHEDULE 13G |
| 2026-04-06 | BNY Mellon High Yield Strategies Fund | Sit Investment Associates, Inc. | 6.3% | SCHEDULE 13G |
| 2026-04-07 | Aclaris Therapeutics, Inc. | RA Capital Management, L.P. | 6.3% | SCHEDULE 13G |
| 2026-04-09 | HMH Holding Inc. | Citadel Advisors LLC | 6.3% | SCHEDULE 13G |
| 2026-04-06 | Associated Banc-Corp | Dianne S. Lozier | 6.28% | SCHEDULE 13G |
| 2026-04-06 | Blackstone Strategic Credit 2027 Term Fund | Sit Investment Associates, Inc. | 6.2% | SCHEDULE 13G |
| 2026-04-07 | Fidelity Greenwood Street Trust | Keybank National Association | 6.2% | SCHEDULE 13G |
| 2026-04-06 | Sea Ltd | WCM Investment Management, LLC | 6.17% | SCHEDULE 13G |
| 2026-04-07 | OnKure Therapeutics, Inc. | Trails Edge Capital Partners, LP | 6% | SCHEDULE 13G |
| 2026-04-07 | Alumis Inc | Deep Track Capital, LP | 5.98% | SCHEDULE 13G |
| 2026-04-08 | PS International Group Ltd. | Lijun Lu | 5.98% | SCHEDULE 13G |
| 2026-04-07 | KPET Ultra Paceline Corporation | Sculptor Capital LP | 5.93% | SCHEDULE 13G |
| 2026-04-08 | HMH Holding Inc. | Millennium Management LLC | 5.9% | SCHEDULE 13G |
| 2026-04-09 | Greenland Energy Company | FG Merchant Partners LP | 5.88% | SCHEDULE 13G |
| 2026-04-10 | California Water Service Group | Amundi | 5.82% | SCHEDULE 13G |
| 2026-04-08 | PS International Group Ltd. | Quanyong Hou | 5.73% | SCHEDULE 13G |
| 2026-04-09 | Kohl's Corp | Dimensional Fund Advisors LP | 5.7% | SCHEDULE 13G |
| 2026-04-07 | Energous Corp | Raymond James Financial Services Advisors, Inc. | 5.6% | SCHEDULE 13G |
| 2026-04-09 | Patterson-UTI Energy, Inc. | Dimensional Fund Advisors LP | 5.6% | SCHEDULE 13G |
| 2026-04-06 | HMH Holding Inc. | Point72 Asset Management, L.P. | 5.5% | SCHEDULE 13G |
| 2026-04-06 | Enviri LLC | Mason Capital Management LLC | 5.5% | SCHEDULE 13G |
| 2026-04-09 | Cleanspark, Inc. | Dimensional Fund Advisors LP | 5.5% | SCHEDULE 13G |
| 2026-04-09 | Ashland Inc | Dimensional Fund Advisors LP | 5.5% | SCHEDULE 13G |
| 2026-04-07 | Firstsun Capital Bancorp | Bay Pond Investors (Bermuda) L.P. | 5.4% | SCHEDULE 13G |
| 2026-04-08 | Orasure Technologies Inc | Neil Gagnon | 5.4% | SCHEDULE 13G |
| 2026-04-08 | PAVmed Inc. | Dols Scott V. | 5.4% | SCHEDULE 13G |
| 2026-04-08 | Creative Media & Community Trust Corp | Jane Street Group, LLC | 5.4% | SCHEDULE 13G |
| 2026-04-09 | ICF International Inc | Dimensional Fund Advisors LP | 5.4% | SCHEDULE 13G |
| 2026-04-09 | ChronoScale Corp | Mink Brook Partners LP | 5.4% | SCHEDULE 13G |
| 2026-04-06 | Brookdale Senior Living Inc | WCM Investment Management, LLC | 5.39% | SCHEDULE 13G |
| 2026-04-06 | Future Money Acquisition Corp | Sculptor Capital LP | 5.35% | SCHEDULE 13G |
| 2026-04-09 | Apogee Acquisition Corp | The K2 Principal Fund, L.P. | 5.33% | SCHEDULE 13G |
| 2026-04-06 | Kezar Life Sciences, Inc. | Baselake Partners, LP | 5.3% | SCHEDULE 13G |
| 2026-04-06 | Abeona Therapeutics Inc. | Funicular Funds, LP | 5.3% | SCHEDULE 13G |
| 2026-04-07 | Firstsun Capital Bancorp | Bay Pond Partners, L.P. | 5.3% | SCHEDULE 13G |
| 2026-04-09 | Dole plc | Dimensional Fund Advisors LP | 5.3% | SCHEDULE 13G |
| 2026-04-09 | Emergent BioSolutions Inc. | Dimensional Fund Advisors LP | 5.3% | SCHEDULE 13G |
| 2026-04-06 | Brainsway Ltd. | Meitav Investment House Ltd | 5.24% | SCHEDULE 13G |
| 2026-04-06 | Brookfield Real Assets Income Fund Inc. | Sit Investment Associates, Inc. | 5.2% | SCHEDULE 13G |
| 2026-04-06 | Zai Lab Limited | RA Capital Management, L.P. | 5.2% | SCHEDULE 13G |
| 2026-04-06 | TherapeuticsMD, Inc. | Baselake Partners, LP | 5.2% | SCHEDULE 13G |
| 2026-04-07 | Nasus Pharma Ltd. | Funicular Funds, LP | 5.2% | SCHEDULE 13G |
| 2026-04-08 | Rmr Group Inc. | FF Hybrid, LP | 5.2% | SCHEDULE 13G |
| 2026-04-09 | Expro Group Holdings N.V. | Dimensional Fund Advisors LP | 5.2% | SCHEDULE 13G |
| 2026-04-09 | ADT Inc | Dimensional Fund Advisors LP | 5.2% | SCHEDULE 13G |
| 2026-04-09 | Capitol Federal Financial Inc | Dimensional Fund Advisors LP | 5.2% | SCHEDULE 13G |
| 2026-04-09 | Visteon Corporation | Dimensional Fund Advisors LP | 5.2% | SCHEDULE 13G |
| 2026-04-09 | Cal-Maine Foods Inc | Dimensional Fund Advisors LP | 5.2% | SCHEDULE 13G |
| 2026-04-09 | Matthews International Corp | Dimensional Fund Advisors LP | 5.2% | SCHEDULE 13G |
| 2026-04-09 | Cytek Biosciences, Inc. | Millennium Management LLC | 5.2% | SCHEDULE 13G |
| 2026-04-09 | A2z Cust2mate Solutions Corp. | Shay Capital LLC | 5.2% | SCHEDULE 13G |
| 2026-04-09 | Blue Water Acquisition Corp. Iv | Wealthspring Capital LLC | 5.2% | SCHEDULE 13G |
| 2026-04-07 | New ERA Energy & Digital, Inc. | Caracola Ventures Corp | 5.1% | SCHEDULE 13G |
| 2026-04-08 | Lenz Therapeutics Inc | Squarepoint Ops LLC | 5.1% | SCHEDULE 13G |
| 2026-04-09 | Liberty Global Ltd. | Dimensional Fund Advisors LP | 5.1% | SCHEDULE 13G |
| 2026-04-09 | Sensata Technologies Holding | Dimensional Fund Advisors LP | 5.1% | SCHEDULE 13G |
| 2026-04-09 | Adapthealth Corp | Dimensional Fund Advisors LP | 5.1% | SCHEDULE 13G |
| 2026-04-09 | Covista Inc | Dimensional Fund Advisors LP | 5.1% | SCHEDULE 13G |
| 2026-04-09 | ZoomInfo Technologies Inc | Dimensional Fund Advisors LP | 5.1% | SCHEDULE 13G |
| 2026-04-09 | HF Sinclair Corp | Dimensional Fund Advisors LP | 5.1% | SCHEDULE 13G |
| 2026-04-09 | Hudson Technologies Inc | Dimensional Fund Advisors LP | 5.1% | SCHEDULE 13G |
| 2026-04-09 | Pacira BioSciences Inc | Dimensional Fund Advisors LP | 5.1% | SCHEDULE 13G |
| 2026-04-09 | Parke Bankcorp, INC | Dimensional Fund Advisors LP | 5.1% | SCHEDULE 13G |
| 2026-04-09 | Herc Holdings Inc | Coliseum Capital Management, LLC | 5.1% | SCHEDULE 13G |
| 2026-04-07 | Advance Auto Parts Inc | Federated Hermes, Inc. | 5.06% | SCHEDULE 13G |
| 2026-04-07 | XFLH Capital Corporation | Shaolin Capital Management LLC | 5.04% | SCHEDULE 13G |
| 2026-04-06 | Blackstone Long-Short Credit Income Fund | Sit Investment Associates, Inc. | 5% | SCHEDULE 13G |
| 2026-04-07 | BrightSpire Capital, Inc. | CWRE SSF Securities Holding, LP | 5% | SCHEDULE 13G |
| 2026-04-07 | Acumen Pharmaceuticals, Inc. | James B. Murray Jr. | 5% | SCHEDULE 13G |
| 2026-04-08 | Rh | Kenneth Griffin | 5% | SCHEDULE 13G |
| 2026-04-09 | First Watch Restaurant Group Inc | Dimensional Fund Advisors LP | 5% | SCHEDULE 13G |
| 2026-04-09 | Happen Inc | Dimensional Fund Advisors LP | 5% | SCHEDULE 13G |
| 2026-04-09 | Pathward Financial Inc | Dimensional Fund Advisors LP | 5% | SCHEDULE 13G |
| 2026-04-09 | Southstate Bank Corp | Dimensional Fund Advisors LP | 5% | SCHEDULE 13G |
| 2026-04-09 | Heartland Express, Inc. | Dimensional Fund Advisors LP | 5% | SCHEDULE 13G |
| 2026-04-09 | MDU Resources Group Inc | Dimensional Fund Advisors LP | 5% | SCHEDULE 13G |
| 2026-04-09 | Shore Bancshares Inc | Dimensional Fund Advisors LP | 5% | SCHEDULE 13G |
| 2026-04-10 | Cybin Inc. | Millennium Management LLC | 5% | SCHEDULE 13G |
Stated intent
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-04-08 | Neuronetics, Inc. | Chernett Jorey intent stated | 14.12% | SCHEDULE 13D/A |
| 2026-04-08 | Novavax, Inc. | Shah Capital Management intent stated | 9.11% | SCHEDULE 13D/A |
| 2026-04-06 | Evotec SE | MAK Capital Fund LP intent stated | 7% | SCHEDULE 13D/A |
Download this data (CSV)213 rows, with sources. Free with an account.
Tools for this story
Each opens in a new tab. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.